Judy E Garber

Judy E Garber

UNVERIFIED PROFILE

Are you Judy E Garber?   Register this Author

Register author
Judy E Garber

Judy E Garber

Publications by authors named "Judy E Garber"

Are you Judy E Garber?   Register this Author

100Publications

3332Reads

23Profile Views

Genetic Testing for Breast Cancer Susceptibility Should Be Offered before Unilateral Abdominally Based Free Flap Breast Reconstruction.

Plast Reconstr Surg 2019 Jul;144(1):12-20

Boston, Mass. From the Harvard Plastic Surgery Combined Residency Program; the Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute; Harvard Medical School; and the Division of Plastic Surgery, Brigham and Women's Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PRS.0000000000005693DOI Listing
July 2019

Trans-counseling: A case series of transgender individuals at high risk for BRCA1 pathogenic variants.

J Genet Couns 2019 Jun 24;28(3):708-716. Epub 2019 Jan 24.

Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/jgc4.1046
Publisher Site
http://dx.doi.org/10.1002/jgc4.1046DOI Listing
June 2019

Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

Breast Cancer Res Treat 2019 May 21;175(1):1-4. Epub 2019 Jan 21.

Division of Surgical Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-018-05117-4DOI Listing
May 2019

Genotype-phenotype associations among panel-based TP53+ subjects.

Genet Med 2019 May 20. Epub 2019 May 20.

Department of Medical Oncology, Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0541-yDOI Listing
May 2019

A counseling framework for moderate-penetrance colorectal cancer susceptibility genes.

Genet Med 2018 11 1;20(11):1324-1327. Epub 2018 Mar 1.

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2018.12DOI Listing
November 2018

Multicenter Phase II Study of Lurbinectedin in BRCA-Mutated and Unselected Metastatic Advanced Breast Cancer and Biomarker Assessment Substudy.

J Clin Oncol 2018 Nov 21;36(31):3134-3143. Epub 2018 Sep 21.

Cristina Cruz and Judith Balmaña, Vall d'Hebron Hospital; Cristina Cruz, Alba Llop-Guevara, Joaquín Arribas, Ana Vivancos, Violeta Serra, and Judith Balmaña, Vall d'Hebron Institute of Oncology; José A. Pérez Fidalgo, Ana Lluch, Joaquín Arribas, and Violeta Serra, Centro de Investigación Biomédica en Red; Joaquín Arribas, Institució Catalana de Recerca i Estudis Avançats, Barcelona; José A. Pérez Fidalgo and Ana Lluch, Hospital Clínico de Valencia, Valencia; Cristian Fernández, Carmen Kahatt, Carlos M. Galmarini, Arturo Soto-Matos, Vicente Alfaro, and Aitor Pérez de la Haza, PharmaMar, Madrid; Silvia Antolin, Complejo Universitario Hospitalario La Coruña, La Coruña; Rafael Lopez, Complejo Hospitalario Universitario Santiago de Compostela, Santiago de Compostela, Spain; Judy E. Garber, Dana Farber Cancer Institute; Nadine M. Tung, Beth Israel Deaconess Medical Center; José Baselga and Steven J. Isakoff, Massachusetts General Hospital Cancer Center, Boston, MA; Banu K. Arun, MD Anderson Cancer Center, Houston, TX; Melinda L. Telli, Stanford University School of Medicine, Stanford, CA; Susan M. Domchek, University of Pennsylvania, Philadelphia, PA; and Linda Vahdat, Weill Cornell Medicine, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2018.78.6558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209089PMC
November 2018

Mixing Mutation Location With Carcinogen Exposure: A Recipe for Tissue Specificity in BRCA2-Associated Cancers?

J Natl Cancer Inst 2018 Sep;110(9):925-926

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy047DOI Listing
September 2018

Differences in TP53 Mutation Carrier Phenotypes Emerge From Panel-Based Testing.

J Natl Cancer Inst 2018 08;110(8):863-870

Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djy001DOI Listing
August 2018

Breast Cancer Surgical Risk Reduction for Patients With Inherited Mutations in Moderate Penetrance Genes.

JAMA Surg 2018 Aug 29. Epub 2018 Aug 29.

Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamasurg.2018.2493DOI Listing
August 2018

A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.

J Community Genet 2018 Jul 18;9(3):233-241. Epub 2017 Nov 18.

Center for Cancer Genetics and Prevention, Division of Population Sciences, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave DA 1122, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s12687-017-0347-z
Publisher Site
http://dx.doi.org/10.1007/s12687-017-0347-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6002308PMC
July 2018

BRCA1/2 testing: therapeutic implications for breast cancer management.

Br J Cancer 2018 Jul 5;119(2):141-152. Epub 2018 Jun 5.

Harvard Medical School, 25 Shattuck Street, Boston, MA, 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41416-018-0127-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6048046PMC
July 2018

Towards Prevention of Breast Cancer: What Are the Clinical Challenges?

Cancer Prev Res (Phila) 2018 05 16;11(5):255-264. Epub 2018 Apr 16.

Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-16-0254DOI Listing
May 2018

Managing hereditary breast cancer risk in women with and without ovarian cancer.

Gynecol Oncol 2017 07 25;146(1):205-214. Epub 2017 Apr 25.

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, MA, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.04.013DOI Listing
July 2017

Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.

J Clin Oncol 2017 Apr 13;35(11):1179-1188. Epub 2017 Feb 13.

Signe Borgquist and Judy E. Garber, Dana-Farber Cancer Institute, Harvard Medical School; Anita Giobbie-Hurder, International Breast Cancer Study Group (IBCSG) Statistical Center, Dana-Farber Cancer Institute; Richard D. Gelber, IBCSG Statistical Center, Dana-Farber Cancer Institute, Harvard Medical School, T.H. Chan Harvard School of Public Health, and Frontier Science and Technology Research Foundation; Karen N. Price, IBCSG Statistical Center and Frontier Science and Technology Research Foundation; Meredith M. Regan, IBCSG Statistical Center, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA; Signe Borgquist, Lund University, Lund, Sweden; Thomas P. Ahern, University of Vermont, Burlington, VT; Marco Colleoni and Aron Goldhirsch, IBCSG and European Institute of Oncology, Milan, Italy; István Láng, IBCSG and National Institute of Oncology, Budapest, Hungary; Marc Debled, Institut Bergonié, Bordeaux, France; Bent Ejlertsen, Danish Breast Cancer Cooperative Group, Rigshospitalet, Copenhagen, Denmark; Roger von Moos, Cantonal Hospital Graubuenden, Chur; Swiss Group for Clinical Cancer Research and IBCSG; Manuela Rabaglio, IBCSG Coordinating Center and Inselspital, Bern; Beat Thürlimann, Breast Center St. Gallen, Kantonsspital, St. Gallen; Swiss Group for Clinical Cancer Research and IBCSG, Bern, Switzerland; Ian Smith, The Royal Marsden Hospital, London, United Kingdom; and Alan S. Coates, IBCSG and University of Sydney School of Public Health, Sydney, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.3116DOI Listing
April 2017

Reply to S.M. Sorscher and M.J. Hall et al.

J Clin Oncol 2016 12 31;34(34):4187-4188. Epub 2016 Oct 31.

Nadine M. Tung, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA; and Judy E. Garber, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.1022DOI Listing
December 2016

Conflicting Interpretation of Genetic Variants and Cancer Risk by Commercial Laboratories as Assessed by the Prospective Registry of Multiplex Testing.

J Clin Oncol 2016 12 30;34(34):4071-4078. Epub 2016 Sep 30.

Judith Balmaña, Hospital Vall d'Hebron and Universitat Autònoma de Barcelona, Barcelona, Spain; Laura Digiovanni, Susan M. Domchek, and Katherine L. Nathanson, University of Pennsylvania, Philadelphia, PA; Pragna Gaddam, Michael F. Walsh, Vijai Joseph, Zsofia K. Stadler, Kenneth Offit, and Mark E. Robson, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY; Judy E. Garber, Dana-Farber Cancer Institute, Boston, MA; and Fergus J. Couch, Mayo Clinic, Rochester, MN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.68.4316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562435PMC
December 2016

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.

Breast Cancer Res Treat 2016 12 12;160(3):393-410. Epub 2016 Oct 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-4003-9DOI Listing
December 2016

Counselling framework for moderate-penetrance cancer-susceptibility mutations.

Nat Rev Clin Oncol 2016 09 14;13(9):581-8. Epub 2016 Jun 14.

Clinical Genetics Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue; and the Weill Cornell Medical College, 1300 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513673PMC
September 2016

The Effect of Atorvastatin on Breast Cancer Biomarkers in High-Risk Women.

Cancer Prev Res (Phila) 2016 05 23;9(5):379-84. Epub 2016 Feb 23.

Department of Medicine, University of Vermont, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1940-6207.CAPR-15-0300DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965880PMC
May 2016

Frequency of Germline Mutations in 25 Cancer Susceptibility Genes in a Sequential Series of Patients With Breast Cancer.

J Clin Oncol 2016 May 14;34(13):1460-8. Epub 2016 Mar 14.

Nadine Tung, Beth Israel Deaconess Medical Center; Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Dana-Farber Cancer Institute; Nadine Tung, Nancy U. Lin, Eric P. Winer, and Judy E. Garber, Harvard Medical School, Boston, MA; and John Kidd, Brian A. Allen, Nanda Singh, Richard J. Wenstrup, and Anne-Renee Hartman, Myriad Genetic Laboratories, Inc., Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.0747DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872307PMC
May 2016

CANCER. The cancer predisposition revolution.

Science 2016 May;352(6289):1052-3

Sage Bionetworks, Seattle, WA 98109, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.aag0832DOI Listing
May 2016

Cancer Survivorship Care: An Opportunity to Revisit Cancer Genetics.

J Clin Oncol 2016 Feb 28;34(6):539-41. Epub 2015 Dec 28.

Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.5375DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872029PMC
February 2016

A Cross-Cancer Genetic Association Analysis of the DNA Repair and DNA Damage Signaling Pathways for Lung, Ovary, Prostate, Breast, and Colorectal Cancer.

Cancer Epidemiol Biomarkers Prev 2016 Jan 4;25(1):193-200. Epub 2015 Dec 4.

Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina. Cancer Prevention, Detection, and Control Research Program, Duke Cancer Institute, Durham, North Carolina. Department of Public Health Sciences, University of Virginia, Charlottesville, Virginia.

View Article

Download full-text PDF

Source
http://cebp.aacrjournals.org/content/25/1/193.full.pdf
Web Search
http://cebp.aacrjournals.org/cgi/doi/10.1158/1055-9965.EPI-1
Publisher Site
http://dx.doi.org/10.1158/1055-9965.EPI-15-0649DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4713268PMC
January 2016

Statin Use and Breast Cancer Risk in the Nurses' Health Study.

Cancer Epidemiol Biomarkers Prev 2016 Jan;25(1):201-6

Departments of Surgery and Biochemistry, University of Vermont College of Medicine, Burlington, Vermont.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-15-0654DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4842011PMC
January 2016

THE GORDON WILSON LECTURE EVOLUTION OF CLINICAL CANCER GENETICS.

Authors:
Judy E Garber

Trans Am Clin Climatol Assoc 2016;127:127-139

BOSTON, MASSACHUSETTS.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216520PMC
January 2016

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

J Clin Oncol 2015 Oct 17;33(28):3092-5. Epub 2015 Aug 17.

Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2015.60.8596
Publisher Site
http://dx.doi.org/10.1200/JCO.2015.60.8596DOI Listing
October 2015

PARP inhibitors in the management of breast cancer: current data and future prospects.

BMC Med 2015 Aug 13;13:188. Epub 2015 Aug 13.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12916-015-0425-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4535298PMC
August 2015

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.

J Clin Oncol 2015 Jun 6;33(17):1902-9. Epub 2015 Apr 6.

Steven J. Isakoff, Lei He, Darrel R. Borger, Dianne M. Finkelstein, Paula D. Ryan, Paul E. Goss, and Leif W. Ellisen, Massachusetts General Hospital Cancer Center; Steven J. Isakoff, Erica L. Mayer, Lei He, Karen Krag, Steven E. Come, Darrel R. Borger, Dianne M. Finkelstein, Judy E. Garber, Paula D. Ryan, Eric P. Winer, Paul E. Goss, and Leif W. Ellisen, Harvard Medical School; Erica L. Mayer, Judy E. Garber, and Eric P. Winer, Dana-Farber Cancer Institute; Steven E. Come, Beth Israel Deaconess Medical Center, Boston; Karen Krag, Massachusetts General Hospital/North Shore Cancer Center, Danvers, MA; Tiffany A. Traina, Memorial Sloan Kettering Cancer Center, New York, NY; Lisa A. Carey, The University of North Carolina at Chapel Hill, Chapel Hill, NC; Hope S. Rugo, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; Minetta C. Liu, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC; Vered Stearns, The Johns Hopkins University School of Medicine and The Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD; Kirsten Timms, Myriad Genetics; and Anne-Renee Hartman, Myriad Genetic Laboratories, Salt Lake City, UT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.6660DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451173PMC
June 2015

Women's concerns about the emotional impact of awareness of heritable breast cancer risk and its implications for their children.

J Community Genet 2015 Jan 7;6(1):55-62. Epub 2014 Aug 7.

Georgetown Lombardi Comprehensive Cancer Center, 3300 Whitehaven Street, NW, Suite 4100, Washington, DC, 20007, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12687-014-0201-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286561PMC
January 2015

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.

Cancer 2015 Jan 3;121(1):25-33. Epub 2014 Sep 3.

Division of Hematology-Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29010DOI Listing
January 2015

Parent decision-making around the genetic testing of children for germline TP53 mutations.

Cancer 2015 Jan 15;121(2):286-93. Epub 2014 Sep 15.

Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29027DOI Listing
January 2015

Addressing sexual dysfunction after risk-reducing salpingo-oophorectomy: effects of a brief, psychosexual intervention.

J Sex Med 2015 Jan 14;12(1):189-97. Epub 2014 Oct 14.

Dana-Farber Cancer Institute, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/jsm.12713DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4304978PMC
January 2015

Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:
Paolo Peterlongo Jenny Chang-Claude Kirsten B Moysich Anja Rudolph Rita K Schmutzler Jacques Simard Penny Soucy Rosalind A Eeles Douglas F Easton Ute Hamann Stefan Wilkening Bowang Chen Matti A Rookus Marjanka K Schmidt Frederieke H van der Baan Amanda B Spurdle Logan C Walker Felicity Lose Ana-Teresa Maia Marco Montagna Laura Matricardi Jan Lubinski Anna Jakubowska Encarna B Gómez Garcia Olufunmilayo I Olopade Robert L Nussbaum Katherine L Nathanson Susan M Domchek Timothy R Rebbeck Banu K Arun Beth Y Karlan Sandra Orsulic Jenny Lester Wendy K Chung Alex Miron Melissa C Southey David E Goldgar Saundra S Buys Ramunas Janavicius Cecilia M Dorfling Elizabeth J van Rensburg Yuan Chun Ding Susan L Neuhausen Thomas V O Hansen Anne-Marie Gerdes Bent Ejlertsen Lars Jønson Ana Osorio Cristina Martínez-Bouzas Javier Benitez Edye E Conway Kathleen R Blazer Jeffrey N Weitzel Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Giulietta Scuvera Monica Barile Filomena Ficarazzi Frederique Mariette Stefano Fortuzzi Alessandra Viel Giuseppe Giannini Laura Papi Aline Martayan Maria Grazia Tibiletti Paolo Radice Athanassios Vratimos Florentia Fostira Judy E Garber Alan Donaldson Carole Brewer Claire Foo D Gareth R Evans Debra Frost Diana Eccles Angela Brady Jackie Cook Marc Tischkowitz Julian Adlard Julian Barwell Lisa Walker Louise Izatt Lucy E Side M John Kennedy Mark T Rogers Mary E Porteous Patrick J Morrison Radka Platte Rosemarie Davidson Shirley V Hodgson Steve Ellis Trevor Cole Andrew K Godwin Kathleen Claes Tom Van Maerken Alfons Meindl Andrea Gehrig Christian Sutter Christoph Engel Dieter Niederacher Doris Steinemann Hansjoerg Plendl Karin Kast Kerstin Rhiem Nina Ditsch Norbert Arnold Raymonda Varon-Mateeva Barbara Wappenschmidt Shan Wang-Gohrke Brigitte Bressac-de Paillerets Bruno Buecher Capucine Delnatte Claude Houdayer Dominique Stoppa-Lyonnet Francesca Damiola Isabelle Coupier Laure Barjhoux Laurence Venat-Bouvet Lisa Golmard Nadia Boutry-Kryza Olga M Sinilnikova Olivier Caron Pascal Pujol Sylvie Mazoyer Muriel Belotti Marion Piedmonte Michael L Friedlander Gustavo C Rodriguez Larry J Copeland Miguel de la Hoya Pedro Perez Segura Heli Nevanlinna Kristiina Aittomäki Theo A M van Os Hanne E J Meijers-Heijboer Annemarie H van der Hout Maaike P G Vreeswijk Nicoline Hoogerbrugge Margreet G E M Ausems Helena C van Doorn J Margriet Collée Edith Olah Orland Diez Ignacio Blanco Conxi Lazaro Joan Brunet Lidia Feliubadalo Cezary Cybulski Jacek Gronwald Katarzyna Durda Katarzyna Jaworska-Bieniek Grzegorz Sukiennicki Adalgeir Arason Jocelyne Chiquette Manuel R Teixeira Curtis Olswold Fergus J Couch Noralane M Lindor Xianshu Wang Csilla I Szabo Kenneth Offit Marina Corines Lauren Jacobs Mark E Robson Liying Zhang Vijai Joseph Andreas Berger Christian F Singer Christine Rappaport Daphne Geschwantler Kaulich Georg Pfeiler Muy-Kheng M Tea Catherine M Phelan Mark H Greene Phuong L Mai Gad Rennert Anna Marie Mulligan Gord Glendon Sandrine Tchatchou Irene L Andrulis Amanda Ewart Toland Anders Bojesen Inge Sokilde Pedersen Mads Thomassen Uffe Birk Jensen Yael Laitman Johanna Rantala Anna von Wachenfeldt Hans Ehrencrona Marie Stenmark Askmalm Åke Borg Karoline B Kuchenbaecker Lesley McGuffog Daniel Barrowdale Sue Healey Andrew Lee Paul D P Pharoah Georgia Chenevix-Trench Antonis C Antoniou Eitan Friedman

Cancer Epidemiol Biomarkers Prev 2015 Jan 21;24(1):308-16. Epub 2014 Oct 21.

Sheba Medical Center, Tel Aviv, Israel.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-14-0532DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294951PMC
January 2015

Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers.

Breast Cancer Res Treat 2014 Nov 14;148(2):397-406. Epub 2014 Oct 14.

Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, The University of Pennsylvania School of Medicine, 2 Blockley Hall, 423 Guardian Drive, Philadelphia, PA, 19104-6021, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-014-3134-0
Publisher Site
http://dx.doi.org/10.1007/s10549-014-3134-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4224991PMC
November 2014

BRCA1 haploinsufficiency for replication stress suppression in primary cells.

Nat Commun 2014 Nov 17;5:5496. Epub 2014 Nov 17.

1] Harvard Medical School, Boston, Massachusetts 02115, USA [2] Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/ncomms6496
Publisher Site
http://dx.doi.org/10.1038/ncomms6496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243249PMC
November 2014

Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Health Psychol 2014 Aug 24;33(8):765-73. Epub 2013 Jun 24.

Cancer Prevention & Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1037/a0033418DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883806PMC
August 2014

Outcome of triple negative breast cancer: comparison of sporadic and BRCA1-associated cancers.

Breast Cancer Res Treat 2014 Jul 18;146(1):175-82. Epub 2014 May 18.

Beth Israel Deaconess Medical Center, 330 Brookline Avenue, Boston, MA, 02215, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2995-6DOI Listing
July 2014

Germline TP53 mutations and the changing landscape of Li-Fraumeni syndrome.

Hum Mutat 2014 Jun;35(6):654-62

Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/humu.22559DOI Listing
June 2014

Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.

Cancer Epidemiol Biomarkers Prev 2013 Jul;22(7):1260-6

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-0198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703861PMC
July 2013

Prevalence of germline TP53 mutations in HER2+ breast cancer patients.

Breast Cancer Res Treat 2013 May 12;139(1):193-8. Epub 2013 Apr 12.

Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-012-2375-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4280061PMC
May 2013

Multiplex genetic testing for cancer susceptibility: out on the high wire without a net?

J Clin Oncol 2013 Apr 4;31(10):1267-70. Epub 2013 Mar 4.

University of Pennsylvania, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2012.46.9403
Publisher Site
http://dx.doi.org/10.1200/JCO.2012.46.9403DOI Listing
April 2013

A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.

Authors:
Yuan C Ding Lesley McGuffog Sue Healey Eitan Friedman Yael Laitman Shani- Paluch-Shimon Bella Kaufman Annelie Liljegren Annika Lindblom Håkan Olsson Ulf Kristoffersson Marie Stenmark-Askmalm Beatrice Melin Susan M Domchek Katherine L Nathanson Timothy R Rebbeck Anna Jakubowska Jan Lubinski Katarzyna Jaworska Katarzyna Durda Jacek Gronwald Tomasz Huzarski Cezary Cybulski Tomasz Byrski Ana Osorio Teresa Ramóny Cajal Alexandra V Stavropoulou Javier Benítez Ute Hamann Matti Rookus Cora M Aalfs Judith L de Lange Hanne E J Meijers-Heijboer Jan C Oosterwijk Christi J van Asperen Encarna B Gómez García Nicoline Hoogerbrugge Agnes Jager Rob B van der Luijt Douglas F Easton Susan Peock Debra Frost Steve D Ellis Radka Platte Elena Fineberg D Gareth Evans Fiona Lalloo Louise Izatt Ros Eeles Julian Adlard Rosemarie Davidson Diana Eccles Trevor Cole Jackie Cook Carole Brewer Marc Tischkowitz Andrew K Godwin Harsh Pathak Dominique Stoppa-Lyonnet Olga M Sinilnikova Sylvie Mazoyer Laure Barjhoux Mélanie Léoné Marion Gauthier-Villars Virginie Caux-Moncoutier Antoine de Pauw Agnès Hardouin Pascaline Berthet Hélène Dreyfus Sandra Fert Ferrer Marie-Agnès Collonge-Rame Johanna Sokolowska Saundra Buys Mary Daly Alex Miron Mary Beth Terry Wendy Chung Esther M John Melissa Southey David Goldgar Christian F Singer Muy-Kheng Maria Tea Daphne Gschwantler-Kaulich Anneliese Fink-Retter Thomas V O Hansen Bent Ejlertsen Oskar T Johannsson Kenneth Offit Kara Sarrel Mia M Gaudet Joseph Vijai Mark Robson Marion R Piedmonte Lesley Andrews David Cohn Leslie R DeMars Paul DiSilvestro Gustavo Rodriguez Amanda Ewart Toland Marco Montagna Simona Agata Evgeny Imyanitov Claudine Isaacs Ramunas Janavicius Conxi Lazaro Ignacio Blanco Susan J Ramus Lara Sucheston Beth Y Karlan Jenny Gross Patricia A Ganz Mary S Beattie Rita K Schmutzler Barbara Wappenschmidt Alfons Meindl Norbert Arnold Dieter Niederacher Sabine Preisler-Adams Dorotehea Gadzicki Raymonda Varon-Mateeva Helmut Deissler Andrea Gehrig Christian Sutter Karin Kast Heli Nevanlinna Kristiina Aittomäki Jacques Simard Amanda B Spurdle Jonathan Beesley Xiaoqing Chen Gail E Tomlinson Jeffrey Weitzel Judy E Garber Olufunmilayo I Olopade Wendy S Rubinstein Nadine Tung Joanne L Blum Steven A Narod Sean Brummel Daniel L Gillen Noralane Lindor Zachary Fredericksen Vernon S Pankratz Fergus J Couch Paolo Radice Paolo Peterlongo Mark H Greene Jennifer T Loud Phuong L Mai Irene L Andrulis Gord Glendon Hilmi Ozcelik Anne-Marie Gerdes Mads Thomassen Uffe Birk Jensen Anne-Bine Skytte Maria A Caligo Andrew Lee Georgia Chenevix-Trench Antonis C Antoniou Susan L Neuhausen

Cancer Epidemiol Biomarkers Prev 2012 Aug 22;21(8):1362-70. Epub 2012 Jun 22.

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California 91010, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-12-0229DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3415567PMC
August 2012

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

Authors:
Nasim Mavaddat Daniel Barrowdale Irene L Andrulis Susan M Domchek Diana Eccles Heli Nevanlinna Susan J Ramus Amanda Spurdle Mark Robson Mark Sherman Anna Marie Mulligan Fergus J Couch Christoph Engel Lesley McGuffog Sue Healey Olga M Sinilnikova Melissa C Southey Mary Beth Terry David Goldgar Frances O'Malley Esther M John Ramunas Janavicius Laima Tihomirova Thomas V O Hansen Finn C Nielsen Ana Osorio Alexandra Stavropoulou Javier Benítez Siranoush Manoukian Bernard Peissel Monica Barile Sara Volorio Barbara Pasini Riccardo Dolcetti Anna Laura Putignano Laura Ottini Paolo Radice Ute Hamann Muhammad U Rashid Frans B Hogervorst Mieke Kriege Rob B van der Luijt Susan Peock Debra Frost D Gareth Evans Carole Brewer Lisa Walker Mark T Rogers Lucy E Side Catherine Houghton JoEllen Weaver Andrew K Godwin Rita K Schmutzler Barbara Wappenschmidt Alfons Meindl Karin Kast Norbert Arnold Dieter Niederacher Christian Sutter Helmut Deissler Doroteha Gadzicki Sabine Preisler-Adams Raymonda Varon-Mateeva Ines Schönbuchner Heidrun Gevensleben Dominique Stoppa-Lyonnet Muriel Belotti Laure Barjhoux Claudine Isaacs Beth N Peshkin Trinidad Caldes Miguel de la Hoya Carmen Cañadas Tuomas Heikkinen Päivi Heikkilä Kristiina Aittomäki Ignacio Blanco Conxi Lazaro Joan Brunet Bjarni A Agnarsson Adalgeir Arason Rosa B Barkardottir Martine Dumont Jacques Simard Marco Montagna Simona Agata Emma D'Andrea Max Yan Stephen Fox Timothy R Rebbeck Wendy Rubinstein Nadine Tung Judy E Garber Xianshu Wang Zachary Fredericksen Vernon S Pankratz Noralane M Lindor Csilla Szabo Kenneth Offit Rita Sakr Mia M Gaudet Christian F Singer Muy-Kheng Tea Christine Rappaport Phuong L Mai Mark H Greene Anna Sokolenko Evgeny Imyanitov Amanda Ewart Toland Leigha Senter Kevin Sweet Mads Thomassen Anne-Marie Gerdes Torben Kruse Maria Caligo Paolo Aretini Johanna Rantala Anna von Wachenfeld Karin Henriksson Linda Steele Susan L Neuhausen Robert Nussbaum Mary Beattie Kunle Odunsi Lara Sucheston Simon A Gayther Kate Nathanson Jenny Gross Christine Walsh Beth Karlan Georgia Chenevix-Trench Douglas F Easton Antonis C Antoniou

Cancer Epidemiol Biomarkers Prev 2012 Jan 5;21(1):134-47. Epub 2011 Dec 5.

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-11-0775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3272407PMC
January 2012

Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers.

Cancer Discov 2011 Jun 1;1(1):29-34. Epub 2011 Jun 1.

Breast Cancer Center, Medical Oncology Department, University Hospital Vall d'Hebron, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8274.CD-11-0048DOI Listing
June 2011